Kura oncology, inc. (KURA)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10
Assets
Current assets:
Cash and cash equivalents

33,811

26,135

54,742

122,080

17,778

16,119

20,568

17,658

26,518

11,433

23,336

12,154

10,642

9,725

6,783

12,112

16,326

15,443

11,215

19,788

-

1,124

18

4

6

6

10

18

2

4

5

9

23

4

6

9

4

26

Short-term investments

183,124

210,756

195,384

139,333

147,747

162,866

166,855

108,227

111,682

81,712

77,469

41,090

48,511

58,065

67,785

67,978

62,140

70,303

30,017

26,145

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53,571

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, related party

31

30

47

111

179

224

232

230

257

216

209

304

341

295

261

286

406

430

379

372

349

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

4,164

2,682

2,775

2,380

1,882

1,988

2,737

2,420

1,904

1,280

909

1,187

1,134

725

886

1,045

1,203

693

695

884

707

42

0

0

0

2

4

0

1

3

5

6

0

2

4

6

2

2

Total current assets

221,130

239,603

252,948

263,904

167,586

181,197

190,392

128,535

140,361

94,641

101,923

54,735

60,628

68,810

75,715

81,421

80,075

86,869

42,306

47,189

54,627

1,196

-

-

-

-

-

-

4

-

11

15

24

6

10

15

6

29

Property and equipment, net

805

44

-

-

-

-

-

1

5

10

17

24

32

40

47

55

62

71

78

59

34

27

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

210

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

4,317

2,325

1,517

1,587

1,772

1,182

1,108

1,091

1,092

1,200

1,175

1,088

1,259

971

542

268

240

319

438

279

150

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets, related party

-

-

137

194

259

-

-

-

-

-

-

-

-

-

-

-

5

-

5

5

5

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

226,462

241,972

254,602

265,685

169,617

182,379

191,500

129,627

141,458

95,851

103,115

55,847

61,919

69,821

76,304

81,744

80,382

87,259

42,827

47,532

54,816

1,378

18

4

6

9

14

18

-

8

-

-

-

-

-

-

-

-

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued expenses

13,554

15,314

12,865

10,878

11,782

13,615

9,817

9,330

8,724

8,284

6,196

4,179

3,688

4,681

4,184

3,330

3,115

4,118

3,654

2,492

4,469

846

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses, related party

-

-

247

354

361

-

254

437

333

216

342

397

428

770

1,088

1,054

1,195

937

1,057

1,112

1,062

134

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt, net

1,000

250

-

-

-

-

2,834

2,813

2,294

1,531

1,024

500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

8

0

0

0

0

6

1

0

0

3

2

2

2

2

2

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

20

18

17

15

13

12

11

10

8

7

6

-

-

6

2

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

2

7

5

3

2

1

5

1

1

1

5

7

6

5

5

Convertible notes payable, related party, current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,036

125

110

110

110

110

110

85

85

85

85

85

60

60

60

60

60

Total current liabilities

14,554

15,564

13,112

11,232

12,143

13,615

12,905

12,580

11,351

10,031

7,562

5,076

4,116

5,451

5,272

4,384

4,310

5,055

4,711

3,604

5,531

3,016

-

-

-

-

-

-

105

-

97

95

97

74

69

68

74

70

Long-term debt, net

6,500

7,250

7,500

7,500

7,500

7,500

3,432

4,150

4,861

5,567

6,018

6,855

7,339

7,324

7,308

7,292

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

493

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

2,207

377

406

372

385

279

556

500

446

388

336

279

223

170

58

27

-

101

332

604

391

1,295

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities, related party

-

-

-

-

24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

23,261

23,191

21,018

19,104

20,052

21,394

16,893

17,230

16,658

15,986

13,916

12,210

11,678

12,945

12,638

11,703

4,316

5,156

5,043

4,208

5,922

4,811

161

141

136

133

129

126

-

103

-

-

-

-

-

-

-

-

Commitments and contingencies (Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value; 200,000 shares authorized; 45,430 and 45,384 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

5

5

5

5

4

4

4

3

3

3

3

2

2

2

2

2

2

2

1

1

1

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Additional paid-in capital

434,722

431,322

428,259

425,035

313,220

310,849

308,366

231,120

228,759

169,201

167,752

112,866

111,647

110,748

110,162

109,577

108,975

108,484

57,604

57,069

57,040

238

49

49

49

49

49

49

49

49

49

49

49

49

49

49

49

49

Accumulated other comprehensive income

561

331

332

161

18

-131

-123

-93

-68

-49

-14

-22

-19

-18

11

45

11

-87

1

-14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-232,087

-212,877

-195,012

-178,620

-163,677

-149,737

-133,640

-118,633

-103,894

-89,290

-78,542

-69,209

-61,389

-53,856

-46,509

-39,583

-32,922

-26,296

-19,822

-13,732

-8,147

-3,671

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

193

186

179

173

164

158

151

145

135

129

123

118

109

102

118

90

Total stockholders' equity

203,201

218,781

233,584

246,581

149,565

160,985

174,607

112,397

124,800

79,865

89,199

43,637

50,241

56,876

63,666

70,041

76,066

82,103

37,784

43,324

48,894

-3,433

-143

-136

-129

-123

-114

-108

-101

-95

-85

-79

-73

-68

-59

-52

-68

-40

Total liabilities and stockholders' equity

226,462

241,972

254,602

265,685

169,617

182,379

191,500

129,627

141,458

95,851

103,115

55,847

61,919

69,821

76,304

81,744

80,382

87,259

42,827

47,532

54,816

1,378

18

4

6

9

14

18

4

8

11

15

24

6

10

15

6

29